Methazolamide‐Induced Delirium
A 74‐year‐old man became delirious 2 days after beginning oral therapy with methazolamide. The delirium was manifested by intermittent psychosis, incontinence of bowel and bladder, lethargy, and disorientation. These symptoms continued for 25 days despite many changes in his drug regimen, and comple...
Gespeichert in:
| Veröffentlicht in: | Pharmacotherapy 1997-03, Vol.17 (2), p.387-389 |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 389 |
|---|---|
| container_issue | 2 |
| container_start_page | 387 |
| container_title | Pharmacotherapy |
| container_volume | 17 |
| creator | Cyr, Monica Laizure, S. Casey daCunha, Carl M. |
| description | A 74‐year‐old man became delirious 2 days after beginning oral therapy with methazolamide. The delirium was manifested by intermittent psychosis, incontinence of bowel and bladder, lethargy, and disorientation. These symptoms continued for 25 days despite many changes in his drug regimen, and complete laboratory, urologic, and neurologic work‐ups. The symptoms resolved completely within 1 week of discontinuing methazolamide. This is the first case reported of delirium associated with methazolamide not accompanied by a metabolic imbalance. |
| doi_str_mv | 10.1002/j.1875-9114.1997.tb03726.x |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_16013100</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>16013100</sourcerecordid><originalsourceid>FETCH-LOGICAL-c3746-a25baf465d43fc28c5cdeb6d44deea473f38f54132ff49974686a9faa5ebd2613</originalsourceid><addsrcrecordid>eNqVkM1Kw0AUhQdRaq0-glBE3CXOfxJXlvrTQkURXQ-TmTuYkjQ109DWlY_gM_okJjR072ounHPunPshdEFwSDCm1_OQxJEIEkJ4SJIkClcpZhGV4eYA9ffSIepjGkUBxjg-Rifez5sskZz2UC_BsWBM9NHwCVYf-qvMdZFZ-P3-mS5sbcAO7yDPqqwuTtGR07mHs-4doPeH-7fxJJg9P07Ho1lgWMRloKlIteNSWM6cobERxkIqLecWQPOIORY7wQmjzvGmMpex1InTWkBqqSRsgK52e5dV-VmDX6ki8wbyXC-grL0iEhPWXN8Yb3ZGU5XeV-DUssoKXW0VwarFo-aqZaBaBqrFozo8atOEz7tf6rQAu492PBr9stO1Nzp3lV6YzO9tVLKYJm2H251tneWw_UcB9TIZvbYj-wPqdYJJ</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>16013100</pqid></control><display><type>article</type><title>Methazolamide‐Induced Delirium</title><source>MEDLINE</source><source>Access via Wiley Online Library</source><creator>Cyr, Monica ; Laizure, S. Casey ; daCunha, Carl M.</creator><creatorcontrib>Cyr, Monica ; Laizure, S. Casey ; daCunha, Carl M.</creatorcontrib><description>A 74‐year‐old man became delirious 2 days after beginning oral therapy with methazolamide. The delirium was manifested by intermittent psychosis, incontinence of bowel and bladder, lethargy, and disorientation. These symptoms continued for 25 days despite many changes in his drug regimen, and complete laboratory, urologic, and neurologic work‐ups. The symptoms resolved completely within 1 week of discontinuing methazolamide. This is the first case reported of delirium associated with methazolamide not accompanied by a metabolic imbalance.</description><identifier>ISSN: 0277-0008</identifier><identifier>EISSN: 1875-9114</identifier><identifier>DOI: 10.1002/j.1875-9114.1997.tb03726.x</identifier><identifier>PMID: 9085335</identifier><identifier>CODEN: PHPYDQ</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Aged ; Biological and medical sciences ; Carbonic Anhydrase Inhibitors - adverse effects ; Delirium - chemically induced ; Delirium - diagnosis ; Drug toxicity and drugs side effects treatment ; Humans ; Male ; Medical sciences ; Methazolamide - adverse effects ; Pharmacology. Drug treatments ; Toxicity: nervous system and muscle</subject><ispartof>Pharmacotherapy, 1997-03, Vol.17 (2), p.387-389</ispartof><rights>1997 Pharmacotherapy Publications Inc.</rights><rights>1997 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c3746-a25baf465d43fc28c5cdeb6d44deea473f38f54132ff49974686a9faa5ebd2613</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1002%2Fj.1875-9114.1997.tb03726.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1002%2Fj.1875-9114.1997.tb03726.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,780,784,1417,27924,27925,45574,45575</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=2638290$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/9085335$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Cyr, Monica</creatorcontrib><creatorcontrib>Laizure, S. Casey</creatorcontrib><creatorcontrib>daCunha, Carl M.</creatorcontrib><title>Methazolamide‐Induced Delirium</title><title>Pharmacotherapy</title><addtitle>Pharmacotherapy</addtitle><description>A 74‐year‐old man became delirious 2 days after beginning oral therapy with methazolamide. The delirium was manifested by intermittent psychosis, incontinence of bowel and bladder, lethargy, and disorientation. These symptoms continued for 25 days despite many changes in his drug regimen, and complete laboratory, urologic, and neurologic work‐ups. The symptoms resolved completely within 1 week of discontinuing methazolamide. This is the first case reported of delirium associated with methazolamide not accompanied by a metabolic imbalance.</description><subject>Aged</subject><subject>Biological and medical sciences</subject><subject>Carbonic Anhydrase Inhibitors - adverse effects</subject><subject>Delirium - chemically induced</subject><subject>Delirium - diagnosis</subject><subject>Drug toxicity and drugs side effects treatment</subject><subject>Humans</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Methazolamide - adverse effects</subject><subject>Pharmacology. Drug treatments</subject><subject>Toxicity: nervous system and muscle</subject><issn>0277-0008</issn><issn>1875-9114</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1997</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkM1Kw0AUhQdRaq0-glBE3CXOfxJXlvrTQkURXQ-TmTuYkjQ109DWlY_gM_okJjR072ounHPunPshdEFwSDCm1_OQxJEIEkJ4SJIkClcpZhGV4eYA9ffSIepjGkUBxjg-Rifez5sskZz2UC_BsWBM9NHwCVYf-qvMdZFZ-P3-mS5sbcAO7yDPqqwuTtGR07mHs-4doPeH-7fxJJg9P07Ho1lgWMRloKlIteNSWM6cobERxkIqLecWQPOIORY7wQmjzvGmMpex1InTWkBqqSRsgK52e5dV-VmDX6ki8wbyXC-grL0iEhPWXN8Yb3ZGU5XeV-DUssoKXW0VwarFo-aqZaBaBqrFozo8atOEz7tf6rQAu492PBr9stO1Nzp3lV6YzO9tVLKYJm2H251tneWw_UcB9TIZvbYj-wPqdYJJ</recordid><startdate>199703</startdate><enddate>199703</enddate><creator>Cyr, Monica</creator><creator>Laizure, S. Casey</creator><creator>daCunha, Carl M.</creator><general>Blackwell Publishing Ltd</general><general>Pharmacotherapy</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T2</scope><scope>7U2</scope><scope>7U7</scope><scope>C1K</scope></search><sort><creationdate>199703</creationdate><title>Methazolamide‐Induced Delirium</title><author>Cyr, Monica ; Laizure, S. Casey ; daCunha, Carl M.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c3746-a25baf465d43fc28c5cdeb6d44deea473f38f54132ff49974686a9faa5ebd2613</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1997</creationdate><topic>Aged</topic><topic>Biological and medical sciences</topic><topic>Carbonic Anhydrase Inhibitors - adverse effects</topic><topic>Delirium - chemically induced</topic><topic>Delirium - diagnosis</topic><topic>Drug toxicity and drugs side effects treatment</topic><topic>Humans</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Methazolamide - adverse effects</topic><topic>Pharmacology. Drug treatments</topic><topic>Toxicity: nervous system and muscle</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Cyr, Monica</creatorcontrib><creatorcontrib>Laizure, S. Casey</creatorcontrib><creatorcontrib>daCunha, Carl M.</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Health and Safety Science Abstracts (Full archive)</collection><collection>Safety Science and Risk</collection><collection>Toxicology Abstracts</collection><collection>Environmental Sciences and Pollution Management</collection><jtitle>Pharmacotherapy</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Cyr, Monica</au><au>Laizure, S. Casey</au><au>daCunha, Carl M.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Methazolamide‐Induced Delirium</atitle><jtitle>Pharmacotherapy</jtitle><addtitle>Pharmacotherapy</addtitle><date>1997-03</date><risdate>1997</risdate><volume>17</volume><issue>2</issue><spage>387</spage><epage>389</epage><pages>387-389</pages><issn>0277-0008</issn><eissn>1875-9114</eissn><coden>PHPYDQ</coden><abstract>A 74‐year‐old man became delirious 2 days after beginning oral therapy with methazolamide. The delirium was manifested by intermittent psychosis, incontinence of bowel and bladder, lethargy, and disorientation. These symptoms continued for 25 days despite many changes in his drug regimen, and complete laboratory, urologic, and neurologic work‐ups. The symptoms resolved completely within 1 week of discontinuing methazolamide. This is the first case reported of delirium associated with methazolamide not accompanied by a metabolic imbalance.</abstract><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>9085335</pmid><doi>10.1002/j.1875-9114.1997.tb03726.x</doi><tpages>3</tpages></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 0277-0008 |
| ispartof | Pharmacotherapy, 1997-03, Vol.17 (2), p.387-389 |
| issn | 0277-0008 1875-9114 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_16013100 |
| source | MEDLINE; Access via Wiley Online Library |
| subjects | Aged Biological and medical sciences Carbonic Anhydrase Inhibitors - adverse effects Delirium - chemically induced Delirium - diagnosis Drug toxicity and drugs side effects treatment Humans Male Medical sciences Methazolamide - adverse effects Pharmacology. Drug treatments Toxicity: nervous system and muscle |
| title | Methazolamide‐Induced Delirium |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-27T16%3A19%3A01IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Methazolamide%E2%80%90Induced%20Delirium&rft.jtitle=Pharmacotherapy&rft.au=Cyr,%20Monica&rft.date=1997-03&rft.volume=17&rft.issue=2&rft.spage=387&rft.epage=389&rft.pages=387-389&rft.issn=0277-0008&rft.eissn=1875-9114&rft.coden=PHPYDQ&rft_id=info:doi/10.1002/j.1875-9114.1997.tb03726.x&rft_dat=%3Cproquest_cross%3E16013100%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=16013100&rft_id=info:pmid/9085335&rfr_iscdi=true |